Effect of Liposome-Muramyl Tripeptide Combined with Recombinant Canine Granulocyte Colony-Stimulating Factor on Canine Monocyte Activity

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Cancer Biotherapy

• Publication date

  1994-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1089/cbr.1994.9.113PMID 7529085
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vitro and in vivo canine mononuclear cell production of tumor necrosis factor induced by muramyl peptides and lipopolysaccharide.

  1993influential reference
• Hemopoietic Growth Factors: A Review

  1992cited by this paper
• Effects of recombinant canine granulocyte colony-stimulating factor on white blood cell production in clinically normal and neutropenic dogs.

  1992cited by this paper
• Effect of colony-stimulating factors on number and function of circulating monocytes in normal dogs.

  1992cited by this paper
• Therapy of human ovarian cancer xenografts with intraperitoneal liposome encapsulated muramyl-tripeptide phosphoethanolamine (MTP-PE) and recombinant GM-CSF.

  1991cited by this paper
• Activation of macrophages for ADCC in vitro: effects of IL-4, TNF, interferons-alpha/beta, interferon-gamma, and GM-CSF.

  1991cited by this paper
• Activation of macrophages for ADCC in vitro: Effects of IL-4, TNF, interferons-αβ, interferon-γ, and GM-CSF

  1991cited by this paper
• Evaluation of recombinant canine granulocyte colony-stimulating factor as an inducer of granulopoiesis. A pilot study.

  1991cited by this paper
• Cytokine effects and role of adhesive proteins and Fc receptors in human macrophage‐mediated antibody dependent cellular cytotoxicity

  1991cited by this paper
• Macrophage products IL-1 alpha, TNF alpha and bFGF may mediate multiple cytopathic effects in the developing eyes of GM-CSF transgenic mice.

  1990cited by this paper
• Heterogeneity in Responses of Human Blood Monocytes to Granulocyte‐Macrophage Colony‐Stimulating Factor

  1990cited by this paper
• Macrophage products IL-1α, TNFα and bFGF may mediate multiple cytopathic effects in the developing eyes of GM-CSF transgenic mice

  1990cited by this paper
• Administration of bacterial lipopolysaccharide elicits circulating tumor necrosis factor-alpha in neonatal calves

  1990cited by this paper
• GM-CSF enhances 3F8 monoclonal antibody-dependent cellular cytotoxicity against human melanoma and neuroblastoma.

  1989cited by this paper
• Therapy for osteosarcoma in dogs with intravenous injection of liposome-encapsulated muramyl tripeptide.

  1989cited by this paper
• Effect of recombinant granulocyte/macrophage colony-stimulating factor on human monocyte activity in vitro and following intravenous administration.

  1988cited by this paper
• Granulocyte colony-stimulating factor enhances interleukin 3-dependent proliferation of multipotential hemopoietic progenitors.

  1988cited by this paper
• Recognition and destruction of neoplastic cells by activated macrophages: discrimination of altered self.

  1988cited by this paper
• Hemopoietic growth factors: a review.

  1988cited by this paper
• Induction of membrane-associated interleukin 1 by tumor necrosis factor in human fibroblasts.

  1987cited by this paper
• Tumor necrosis factor as effector molecule in monocyte mediated cytotoxicity.

  1986cited by this paper
• Induction of macrophage tumoricidal activity by granulocyte-macrophage colony-stimulating factor.

  1986cited by this paper
• Potentiation of direct antitumor cytotoxicity and production of tumor cytolytic factors in human blood monocytes by human recombinant interferon-gamma and muramyl dipeptide derivatives

  1986cited by this paper
• Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, gamma-interferon and interleukin-1.

  1986cited by this paper
• Comparative analysis of the priming effect of human interferon-gamma, -alpha, and -beta on synergism with muramyl dipeptide analog for anti-tumor expression of human blood monocytes.

  1986cited by this paper
• In vitro activation of rat liver macrophages to tumoricidal activity by free or liposome-encapsulated muramyl dipeptide.

  1986cited by this paper
• Production and characterization of cytostatic protein factors released from human monocytes during exposure to lipopolysaccharide and muramyl dipeptide.

  1985cited by this paper
• Binding of 125I‐labeled granulocyte colony‐stimulating factor to normal murine hemopoietic cells

  1985cited by this paper
• Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro.

  1985cited by this paper
• Activation of macrophage cytostatic and cytotoxic activity in vitro by liposomes containing a new lipophilic muramyl peptide derivative, MDP-L-alanyl-cholesterol (MTP-CHOL).

  1985cited by this paper
• Macrophages and metastasis--a biological approach to cancer therapy.

  1985cited by this paper
• Distribution and fate of free and liposome-encapsulated [3H]nor-muramyl dipeptide and [3H]muramyl tripeptide phosphatidylethanolamine in mice.

  1985cited by this paper
• Synergism between human recombinant gamma-interferon and muramyl dipeptide encapsulated in liposomes for activation of antitumor properties in human blood monocytes.

  1985cited by this paper
• Activation of tumoricidal properties in human blood monocytes by liposomes containing lipophilic muramyl tripeptide.

  1983cited by this paper
• Proliferative effects of purified granulocyte colony‐stimulating factor (G‐CSF) on normal mouse hemopoietic cells

  1983cited by this paper
• Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

  1983cited by this paper
• In vitro activation of tumoricidal properties in rat alveolar macrophages by synthetic muramyl dipeptide encapsulated in liposomes.

  1981cited by this paper
• Evidence for a multistep mechanism of cytolysis by BCG-activated macrophages: the interrelationship between the capacity for cytolysis, target binding, and secretion of cytolytic factor.

  1981cited by this paper
• Characterization of a serum factor stimulating the differentiation of myelomonocytic leukemic cells

  1980cited by this paper
• Fate of the synthetic immunoadjuvant, muramyl dipeptide (14C-labelled) in the mouse.

  1979cited by this paper
• Mechanisms of target cell destruction by alloimmune peritoneal macrophages. II. Release of a specific cytotoxin from interacting cells.

  1971cited by this paper
• Mechanisms of target cell destruction by alloimmune peritoneal macrophages. I. The effect of treatment with sodium fluoride.

  1971cited by this paper

• Canine osteosarcoma: where human and canine research intersect

  2020influential citation
• Utilizing Microbes to Treat Naturally Occurring Cancer in Veterinary Species

  2019cites this paper
• Posteromedial elbow dislocation with lateral humeral condylar fracture in children

  2018cites this paper
• Drugs in early clinical development for the treatment of osteosarcoma

  2016cites this paper
• Comparative oncology today.

  2007cites this paper
• The molecular basis of canine melanoma: pathogenesis and trends in diagnosis and therapy.

  1999cites this paper
• Biological response modifiers: interferons, interleukins, recombinant products, liposomal products.

  1998cites this paper
• Monocyte‐mediated killing of human leukaemia is enhanced by administration of granulocyte‐macrophage colony stimulating factor following chemotherapy

  1997cites this paper